Risk markers for cardiovascular disease

Details for Australian Patent Application No. 2004296829 (hide)

Owner The Cleveland Clinic Foundation

Inventors Zheng, Lemin; Hazen, Stanley; Smith, Jonathan; Zhang, Renliang; Penn, Marc S.

Agent Spruson & Ferguson

Pub. Number AU-A-2004296829

PCT Pub. Number WO2005/055810

Priority 60/527,178 05.12.03 US; 60/600,551 11.08.04 US; 60/600,527 11.08.04 US; 60/619,044 15.10.04 US

Filing date 6 December 2004

Wipo publication date 23 June 2005

International Classifications

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

Event Publications

29 June 2006 PCT application entered the National Phase

  PCT publication WO2005/055810 Priority application(s): WO2005/055810

3 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004296830-Dietary non-essential amino acid tyrosine regulates the body weight of animals through regulating the animal appetite or food intake

2004296828-Methods of protecting against radiation using flagellin